Counterpoint Mutual Funds LLC Makes New $4.72 Million Investment in Astera Labs, Inc. $ALAB

Counterpoint Mutual Funds LLC purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the 1st quarter, HoldingsChannel.com reports. The institutional investor purchased 43,097 shares of the company’s stock, valued at approximately $4,723,000.

A number of other large investors have also modified their holdings of the business. PFG Investments LLC increased its holdings in shares of Astera Labs by 232.5% during the first quarter. PFG Investments LLC now owns 5,935 shares of the company’s stock valued at $650,000 after acquiring an additional 4,150 shares in the last quarter. Sierra Summit Advisors LLC boosted its stake in Astera Labs by 4.8% in the 1st quarter. Sierra Summit Advisors LLC now owns 100,229 shares of the company’s stock worth $10,985,000 after purchasing an additional 4,636 shares in the last quarter. Y Intercept Hong Kong Ltd boosted its stake in Astera Labs by 497.2% in the 1st quarter. Y Intercept Hong Kong Ltd now owns 31,743 shares of the company’s stock worth $3,479,000 after purchasing an additional 26,428 shares in the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund grew its position in Astera Labs by 86.8% during the 1st quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 57,150 shares of the company’s stock worth $6,264,000 after purchasing an additional 26,550 shares during the last quarter. Finally, Elevation Point Wealth Partners LLC purchased a new stake in Astera Labs during the 1st quarter worth approximately $1,215,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Price Performance

Shares of NASDAQ ALAB opened at $406.42 on Friday. Astera Labs, Inc. has a 52 week low of $88.18 and a 52 week high of $499.48. The business’s 50 day moving average price is $314.72 and its 200 day moving average price is $205.55. The firm has a market cap of $69.66 billion, a P/E ratio of 274.61, a P/E/G ratio of 4.66 and a beta of 3.66.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The company had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. Astera Labs’s revenue for the quarter was up 93.5% compared to the same quarter last year. During the same period last year, the firm posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, research analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Insider Activity at Astera Labs

In other Astera Labs news, Director Jack R. Lazar sold 10,000 shares of Astera Labs stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the completion of the transaction, the director owned 75,688 shares in the company, valued at approximately $26,882,106.96. This trade represents a 11.67% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bethany Mayer sold 686 shares of the company’s stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $395.04, for a total value of $270,997.44. Following the completion of the sale, the director owned 5,550 shares in the company, valued at $2,192,472. The trade was a 11.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,981,441 shares of company stock worth $444,969,514 in the last three months. Company insiders own 10.40% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have issued reports on ALAB. JPMorgan Chase & Co. upped their price target on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. UBS Group boosted their price objective on shares of Astera Labs from $205.00 to $400.00 and gave the company a “neutral” rating in a report on Monday. Morgan Stanley upped their target price on Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. Finally, Needham & Company LLC raised their target price on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $265.75.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.